207 related articles for article (PubMed ID: 1994896)
1. The role of metallothionein in the reduction of cisplatin-induced nephrotoxicity by Bi3(+)-pretreatment in the rat in vivo and in vitro. Are antioxidant properties of metallothionein more relevant than platinum binding?
Boogaard PJ; Slikkerveer A; Nagelkerke JF; Mulder GJ
Biochem Pharmacol; 1991 Feb; 41(3):369-75. PubMed ID: 1994896
[TBL] [Abstract][Full Text] [Related]
2. Citrate enhances the protective effect of orally administered bismuth subnitrate against the nephrotoxicity of cis-diamminedichloroplatinum.
Kondo Y; Himeno S; Satoh M; Naganuma A; Nishimura T; Imura N
Cancer Chemother Pharmacol; 2004 Jan; 53(1):33-8. PubMed ID: 14530870
[TBL] [Abstract][Full Text] [Related]
3. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of gentamicin nephrotoxicity in rats and the protective effect of zinc-induced metallothionein synthesis.
Du XH; Yang CL
Nephrol Dial Transplant; 1994; 9 Suppl 4():135-40. PubMed ID: 7800247
[TBL] [Abstract][Full Text] [Related]
5. Protective role of metallothionein in renal toxicity of cisplatinum.
Satoh M; Aoki Y; Tohyama C
Cancer Chemother Pharmacol; 1997; 40(4):358-62. PubMed ID: 9225956
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of cepharanthin on cisplatin-induced renal toxicity through metallothionein expression.
Sogawa N; Hirai K; Sogawa C; Ohyama K; Miyazaki I; Tsukamoto G; Asanuma M; Sasaki A; Kitayama S
Life Sci; 2013 Apr; 92(12):727-32. PubMed ID: 23399700
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor.
Kondo Y; Satoh M; Imura N; Akimoto M
Anticancer Res; 1992; 12(6B):2303-7. PubMed ID: 1295477
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
Yamada T
Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
[TBL] [Abstract][Full Text] [Related]
9. The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney.
Suzuki CA; Cherian MG
Toxicology; 1990 Nov; 64(2):113-27. PubMed ID: 1977210
[TBL] [Abstract][Full Text] [Related]
10. Synergistic protective effect of
Abdel-Wahab WM; Moussa FI; Saad NA
Drug Des Devel Ther; 2017; 11():901-908. PubMed ID: 28356716
[TBL] [Abstract][Full Text] [Related]
11. Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat.
Ramsammy LS; Josepovitz C; Ling KY; Lane BP; Kaloyanides GJ
Biochem Pharmacol; 1987 Jul; 36(13):2125-32. PubMed ID: 3111476
[TBL] [Abstract][Full Text] [Related]
12. [The effect of bismuth subnitrate on cisplatin toxicity].
Chen JT; Kurokawa Y; Nakayama K; Saito K; Sakamoto K; Fukuda K; Hirai Y; Hamada T; Fujimoto I; Yamauchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):815-22. PubMed ID: 3298471
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of tert-butylhydroquinone on cisplatin-induced nephrotoxicity in rats.
Pérez-Rojas JM; Guerrero-Beltrán CE; Cruz C; Sánchez-González DJ; Martínez-Martínez CM; Pedraza-Chaverri J
Food Chem Toxicol; 2011 Oct; 49(10):2631-7. PubMed ID: 21802473
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein-I-transgenic mice are not protected from acute cadmium-metallothionein-induced nephrotoxicity.
Liu YP; Liu J; Palmiter RD; Klaassen CD
Toxicol Appl Pharmacol; 1996 Apr; 137(2):307-15. PubMed ID: 8661357
[TBL] [Abstract][Full Text] [Related]
15. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
Naganuma A; Satoh M; Imura N
Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
[TBL] [Abstract][Full Text] [Related]
16. Induction of renal metallothionein allows increasing dose of an extensively used antitumor drug, cis-diamminedichloroplatinum.
Imura N; Naganuma A; Satoh M; Koyama Y
Experientia Suppl; 1987; 52():655-60. PubMed ID: 2959559
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure.
Liu Y; Liu J; Habeebu SS; Klaassen CD
Toxicol Sci; 1999 Aug; 50(2):221-7. PubMed ID: 10478858
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
[TBL] [Abstract][Full Text] [Related]
19. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
[TBL] [Abstract][Full Text] [Related]
20. Glutathione has a more important role than metallothionein-I/II against inorganic mercury-induced acute renal toxicity.
Tokumoto M; Lee JY; Shimada A; Tohyama C; Satoh M
J Toxicol Sci; 2018; 43(4):275-280. PubMed ID: 29618716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
